Mucosal effects of tenofovir 1% gel

Tenofovir gel is being evaluated for vaginal and rectal pre-exposure prophylaxis against HIV transmission. Because this is a new prevention strategy, we broadly assessed its effects on the mucosa. In MTN-007, a phase-1, randomized, double-blinded rectal microbicide trial, we used systems genomics/pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hladik, Florian, Burgener, Adam, Ballweber, Lamar, Gottardo, Raphael, Vojtech, Lucia, Fourati, Slim, Dai, James Y, Cameron, Mark J, Strobl, Johanna, Hughes, Sean M, Hoesley, Craig, Andrew, Philip, Johnson, Sherri, Piper, Jeanna, Friend, David R, Ball, T Blake, Cranston, Ross D, Mayer, Kenneth H, McElrath, M Juliana, McGowan, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2015
Materias:
Human Biology and Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391502/
https://www.ncbi.nlm.nih.gov/pubmed/25647729
http://dx.doi.org/10.7554/eLife.04525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391502/
https://www.ncbi.nlm.nih.gov/pubmed/25647729
http://dx.doi.org/10.7554/eLife.04525

Ejemplares similares